Price (delayed)
$29.99
Market cap
$2.59B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.33
Enterprise value
$2.21B
IDEAYA Biosciences Inc. is a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates
There are no recent dividends present for IDYA.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.